| 產(chǎn)品編號(hào) | bs-5844R |
| 英文名稱 | Rabbit Anti-SMAGP antibody |
| 中文名稱 | 小細(xì)胞跨膜糖化蛋白抗體 |
| 別 名 | hSMAGP; small cell adhesion glycoprotein; SMAGP_HUMAN; small cell transmembrane and glycosylated protein; small transmembrane and glycosylated protein. |
 |
Specific References (2) | bs-5844R has been referenced in 2 publications.
[IF=3.391] Hongzao Ni. et al. SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/Akt pathway. Arch Biochem Biophys. 2020 Nov;695:108628 WB ; Human.
[IF=2.656] Jia et al. SMAGP a novel biomarker of cervical cancer development and progression. (2018) Onco.Targets.Ther. 11:6925-6935 IHC&IF ;
|
| 研究領(lǐng)域 | 腫瘤 免疫學(xué) 細(xì)胞粘附分子 腫瘤細(xì)胞生物標(biāo)志物 |
| 抗體來源 | Rabbit |
| 克隆類型 | Polyclonal |
| 交叉反應(yīng) | (predicted: Human) |
| 產(chǎn)品應(yīng)用 | WB=1:500-2000,IHC-P=1:100-500,IHC-F=1:100-500,IF=1:100-500,ELISA=1:5000-10000
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理論分子量 | 11kDa |
| 細(xì)胞定位 | 細(xì)胞漿 細(xì)胞膜 |
| 性 狀 | Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human SMAGP: 24-80/97 <Extracellular> |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 緩 沖 液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| 保存條件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 產(chǎn)品介紹 | |
